Skip to main content
LITS logo

Lite Strategy, Inc.

LITSNASDAQHealthcareBiotechnology

$1.20Today:- (-)1Y −36.44%

As of Oct 15, 2026 close

Market cap
$41.30M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.69$2.26
Volume (live)
-
Avg. volume (3M)
773.50K

Lite Strategy (LITS) Stock Price & Financial Analysis

Lite Strategy Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$1.14 - $1.21
52-Week High$2.26
52-Week Low$0.69
Open$1.20
Volume (last close)115.67K
Average Volume (3M)773.50K
Technical Indicators
50-Day MA$1.11
200-Day MA$1.11
1-Year Change−36.44%
Size & Valuation
Market Cap41.30M
Shares Outstanding34.56M
Price to Book (P/B)0.99
EV/EBITDA-2.99
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateNov 16, 2023

Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology

Compare LITS with other stocks

Lite Strategy at a Glance

As of the Oct 16, 2026 close, Lite Strategy (LITS) has a market capitalization of $41.30M. Revenue fell 100.0% year over year.

As of its latest reported balance sheet, it holds $5.71M in cash and securities against $0.00 of debt, a net cash position of $5.71M.

Lite Strategy does not currently pay a dividend.

The share price is down 36.4% over the past year. At $1.15 (the Oct 16, 2026 close) it sits within its 52-week range of $0.69 to $2.26, above its 200-day moving average of $1.11.

Frequently Asked Questions About Lite Strategy

What is the current stock price for LITS?

As of the Oct 16, 2026 close, LITS stock trades at $1.15. The 52-week range is $0.69–$2.26, with a day range of $1.14–$1.21.

What is the P/E ratio for LITS?

The P/E ratio (Price-to-Earnings) for LITS is shown in the Key Statistics section. This valuation metric helps compare Lite Strategy, Inc. to industry peers.

Does LITS pay dividends?

Lite Strategy does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.

What do analysts recommend for LITS?

Analyst ratings and recommendations for LITS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of LITS?

As of the Oct 16, 2026 close, Lite Strategy's market capitalization is $39.7M, classifying it as a micro-cap company. Lite Strategy operates in the Healthcare sector within the Biotechnology industry.